Page 7 - Akebia Therapeutics Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Akebia therapeutics inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Akebia Therapeutics Inc Today - Breaking & Trending Today

Investment Analysts' Price Target Changes for March 28th (AKBA, ALLY, AROC, ATEC, AXP, AXSM, BAC, BRZE, BWXT, CCL)

Investment Analysts’ price target changes for Thursday, March 28th: Akebia Therapeutics (NASDAQ:AKBA) had its price target raised by HC Wainwright from $5.00 to $6.00. The firm currently has a buy rating on the stock. Ally Financial (NYSE:ALLY) had its target price increased by Evercore ISI from $41.00 to $43.00. Evercore ISI currently has an in-line […] ....

United States , Roth Mkm , Piper Sandler , Moffett Nathanson , Stifel Nicolaus , Robertw Baird , Evolent Health , Education Technology Group , Oppenheimer Holdings Inc , Health Services , Citigroup Inc , Highwoods Properties , Deutsche Bank Aktiengesellschaft , Barrington Research , Us Bancorp , Carnival Co , Truist Financial Co , Mt Bank , National Association , Telsey Advisory Group , Royal Bank , Canadian National Railway , News Ratings For Akebia Therapeutics Inc Daily , Goldman Sachs Group , Needham Company , Mereo Biopharma Group ,

Cintas Reports Upbeat Earnings, Joins PaySign, Noah Holdings And Other Big Stocks Moving Higher On Wednesday - Cintas (NASDAQ:CTAS), Noah Holdings (NYSE:NOAH), PaySign (NASDAQ:PAYS)

U.S. stocks were higher, with the Dow Jones index gaining around 300 points on Wednesday. ....

Ew Scripps Company , Novocure Limited , Cintas Corporation , Semtech Corporation , Kohl Corporation , Akebia Therapeutics Inc , Merck Co Inc , Safflower Holdings , Marvell Technology Inc , Lexicon Pharmaceuticals Inc , Noah Holdings Limited , Cino Inc , Annexon Inc , Trump Media Technology Group Corp , Group Hospitality Inc , Dow Jones , Wayfair Inc , Paysign Inc , Nuvation Bio Inc ,

Akebia Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results

Akebia Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

United Kingdom , United States , Akebia Therapeutics Inc , Drug Administration , Drug User Fee Act ,

Akebia Therapeutics To Report Fourth Quarter And Full Year 2023 Financial Results

Akebia Therapeutics To Report Fourth Quarter And Full Year 2023 Financial Results
menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.

United Kingdom , United States , Mercedes Carrasco , Akebia Therapeutics Inc , Drug Administration , Drug User Fee Act ,

Insider Selling: Akebia Therapeutics, Inc. (NASDAQ:AKBA) SVP Sells 24,311 Shares of Stock

Akebia Therapeutics, Inc. (NASDAQ:AKBA – Get Free Report) SVP Steven Keith Burke sold 24,311 shares of the business’s stock in a transaction dated Thursday, February 1st. The stock was sold at an average price of $1.68, for a total transaction of $40,842.48. Following the completion of the sale, the senior vice president now owns 711,376 […] ....

Steven Keith Burke , Akebia Therapeutics Inc , Mirabella Financial Services , Archer Investment Corp , Mackenzie Financial Corp , Raymond James Associates , Akebia Therapeutics , Get Free Report , Keith Burke , Therapeutics Trading Down , Investment Corp , Financial Corp , Akebia Therapeutics Daily , Nasdaq Akba , Insider Trading , Nsider Trades ,